Performance status-3 - Symptomatic, 50 in bed - Page 2 of 2 Posts on Medivizor
Navigation Menu

Performance status-3 – Symptomatic, 50 in bed Posts on Medivizor

Radiofrequency ablation as a treatment for pulmonary metastases after surgical treatment for liver metastases from colorectal cancer

Posted by on Apr 21, 2013 in Colorectal cancer | 0 comments

In a nutshell This study looked at the use of radiofrequency ablation (RFA) as a treatment for colorectal cancer which has spread to the lungs (pulmonary metastasis). Overall, the results showed that RFA treatment gives patients a better survival rate than the previous method of systemic chemotherapy which used to be the best treatment option for...

Read More

The utility of Microwave ablation therapy in the treatment of pulmonary metastases

Posted by on Apr 8, 2013 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to evaluate the safety and efficacy of microwave ablation therapy on pulmonary metastases (cancer spread to the lungs) that cannot be removed surgically. The study showed that it can be an effective treatment method with a success rate depending on the tumor size. Some background Pulmonary metastases...

Read More

A minimally invasive surgical technique called radiofrequency ablation and its use to treat pulmonary metastatic tumours from colorectal cancer

Posted by on Mar 23, 2013 in Colorectal cancer | 0 comments

In a nutshell This paper looks at a new method of treating pulmonary metastases (spread of colorectal cancer to the lungs). This new treatment is called radiofrequency ablation.  The authors showed that this technique can prevent local tumor progression for extended periods of time and offers good overall survival rates. Some background When...

Read More

Efficacy of anti-PD-1 drugs on cancer regression

Posted by on Mar 19, 2013 in Colorectal cancer | 0 comments

In a nutshell This review provided the long-term outcomes of the first human trial of the anti-PD-1 drug BMS-936558. It also evaluated whether restarting therapy for cancer recurrences can be effective. Results showed that anti-PD-1 drugs have clinical potential. Some background The PD-1 protein (or "programmed cell death-1" protein)...

Read More

Treating recurrent rectal caner that invades the pelvic area: major surgical options

Posted by on Mar 13, 2013 in Colorectal cancer | 0 comments

In a nutshell This article reviewed several clinical studies where radical surgical procedures have been used to treat rectal cancer that has invaded the area of the pelvis.  Some background The sacrum bone is the lowest part of the spine which sits between the hip bones.  It is made up of 5 vertebrae which are separate bones during...

Read More

Bosutinib: a new drug that increases progression free survival in patients with locally advanced or metastatic breast cancer

Posted by on Mar 11, 2013 in Breast cancer | 0 comments

In a nutshell This paper presents the results of a clinical study which looked at the use of a new drug called Bosutinib (Bosulif) for the treatment of breast cancers diagnosed as being stage III or IV. In patients previously treated with chemotherapy, Bosutinib showed promising efficacy in delaying cancer progression. Some background Locally...

Read More

Calcium and magnesium infusions for the treatment of Oxaliplatin-related neuropathy

Posted by on Feb 26, 2013 in Colorectal cancer | 1 comment

In a nutshell This article evaluates the use of Calcium and magnesium (Ca/Mg) infusions for the prevention of Oxaliplatin-related neurological side effects in patients with colorectal cancer (CRC). The main findings were that Ca/Mg helps preventing neuro-toxic side effects of Oxaliplatin-based chemotherapy regimens. Some background...

Read More